Chutima Talabnin

6PUBLICATIONS
13CO-AUTHORS
Haematological tumoursGlycoconjugatesRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 11, 2025
In vitro properties of four benign meningioma cells derived from WHO grade 1 meningiomas.

Thanawat Trasaktaweesakul, Pundit Asavaritikrai, Krajang Talabnin

|Jan 06, 2024
Enzymatic synthesis of phenolic acid glucosyl esters to test activities on cholangiocarcinoma cells.

Eko Suyanto, Jaggaiah N Gorantla, Maniganda Santi

|Aug 08, 2022
3D high resolution clonogenic survival measurement of xrs-5 cells in low-dose region of carbon ion plans.

Dea Kartini, Olga Sokol, Chutima Talabnin

|Mar 25, 2022
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway.

Piyasiri Chueakwon, Peeranat Jatooratthawichot, Krajang Talabnin

|Feb 25, 2022
Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.

Juthamas Khiaowichit, Chutima Talabnin, Chavaboon Dechsukhum

|Sep 16, 2017
Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.

Sunisa Thongsom, Wipa Suginta, Kyung Jin Lee

Pageof 1